China's Kelun Biotech snaps $581m at pre-money valuation of $871m

China's Kelun Biotech snaps $581m at pre-money valuation of $871m

Photo by National Cancer Institute on Unsplash

Stephanie Li

05 January, 2023

Kelun BiotechKelun Pharmaceutical

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.